Literature DB >> 2779967

Dysthyroid optic neuropathy without extraocular muscle involvement.

R L Anderson1, J P Tweeten, J R Patrinely, P E Garland, S M Thiese.   

Abstract

We present three atypical cases of dysthyroid optic neuropathy. The unique feature was progressive visual field loss with normal-sized or minimally enlarged extraocular muscles. Other atypical findings included optic nerves that appeared to be linearly on stretch with only moderate proptosis, good ocular motility, and only mildly reduced central visual acuity and color vision despite severe field loss. These cases responded rapidly to decompressive surgery after failing high-dose corticosteroid therapy. While marked enlargement of the extraocular muscles with apical optic nerve compression has been documented to cause dysthyroid optic neuropathy, another etiology such as short optic nerves on stretch appears to be at work in these atypical cases. Although extraocular muscle enlargement is the most important diagnostic feature and indicator of the severity of Graves' ophthalmology, our atypical cases demonstrate that this sign alone is an inadequate basis for diagnosis and visual prognosis.

Entities:  

Mesh:

Year:  1989        PMID: 2779967

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  15 in total

1.  Reversal of dysthyroid optic neuropathy following orbital fat decompression.

Authors:  M Kazim; S L Trokel; G Acaroglu; A Elliott
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy.

Authors:  H C Kim; S W Yoon; H Lew
Journal:  Br J Radiol       Date:  2015-07-07       Impact factor: 3.039

Review 3.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 4.  Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.

Authors:  Seethalakshmi Iyer; Rebecca Bahn
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

5.  Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy.

Authors:  Chan Jeon; Jae Ho Shin; Kyung In Woo; Yoon-Duck Kim
Journal:  Korean J Ophthalmol       Date:  2012-03-22

6.  Increased Orbital Muscle Fraction Diagnosed by Semi-Automatic Volumetry: A Risk Factor for Severe Visual Impairment with Excellent Response to Surgical Decompression in Graves' Orbitopathy.

Authors:  Christine Steiert; Sebastian Kuechlin; Waseem Masalha; Juergen Beck; Wolf Alexander Lagrèze; Juergen Grauvogel
Journal:  J Pers Med       Date:  2022-06-06

7.  Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.

Authors:  Alexander D Blandford; Dalia Zhang; Rao V Chundury; Julian D Perry
Journal:  Expert Rev Ophthalmol       Date:  2017-01-27

Review 8.  Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy.

Authors:  Allan C Pieroni Gonçalves; Eloísa M M S Gebrim; Mário L R Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

9.  Diagnostic ability of Barrett's index to detect dysthyroid optic neuropathy using multidetector computed tomography.

Authors:  Mário L R Monteiro; Allan C P Gonçalves; Carla T M Silva; Janete P Moura; Carolina S Ribeiro; Eloisa M M S Gebrim
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

10.  Orbital Volumetry in Graves' Orbitopathy: Muscle and Fat Involvement in relation to Dysthyroid Optic Neuropathy.

Authors:  Moug Al-Bakri; Ase Krogh Rasmussen; Carsten Thomsen; Peter Bjerre Toft
Journal:  ISRN Ophthalmol       Date:  2014-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.